Trials / Active Not Recruiting
Active Not RecruitingNCT05905575
A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults
A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults With Type 2 Diabetes
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 208 (estimated)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
A family dyad-focused diabetes self-management for African American adults with type 2 diabetes is a randomized controlled trial (RCT) that aims to test the feasibility, acceptability, and efficacy of a family-dyad focused intervention on glycemic control (hemoglobin A1c) and health-related quality of life (HRQOL) in African American adults with type 2 diabetes (T2D).
Detailed description
Eligible participants and their family members will be randomly assigned to either the intervention and control group. Patient-family-member dyads in the intervention arm will virtually receive 1) 10 session over 12 weeks of family dyad-focused, group sessions on diabetes self-management and family support; 2) family dyad-focused support component in each group session; and 3) individual family feedback telephone sessions. All participants will be assessed at baseline, post-intervention and six months after intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Family dyad diabetes intervention | The goals of the intervention are to encourage participants to (1) daily self-manage diabetes and stress; (2) establish a healthy eating pattern; (3) engage in brisk walking of 150 or more minutes a week; and (4) use solution-focused problem-solving strategy and supportive family communication skills. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2027-01-31
- Completion
- 2027-01-31
- First posted
- 2023-06-15
- Last updated
- 2026-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05905575. Inclusion in this directory is not an endorsement.